B. BRAUN MEDICAL

Lobbying for B. BRAUN MEDICAL · Manufacturing

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 16, 2026

Expenses

$118,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Pennsylvania

Official filing document

Government bodies contacted 4

Commerce, Dept of (DOC)
HOUSE OF REPRESENTATIVES
SENATE
U.S. Trade Representative (USTR)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 4

Consumer Issues/Safety/Products

FDA issues drug and device shortages

Health Issues

generic pharmaceutical and medical device issues

Tariff (miscellaneous tariff bills)

drug and device shortage issues

Pharmacy

drug quality security act, 503A and 503B pharmacy issues

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.